Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | multiple endocrine neoplasia I | No references | |
Homo sapiens | acid phosphatase 1, soluble | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable acyl-[acyl-carrier protein] desaturase DesA1 (acyl-[ACP] desaturase) (stearoyl-ACP desaturase) (protein Des) | acid phosphatase 1, soluble | 112 aa | 107 aa | 24.3 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.009 | 0.0074 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0074 | 0.0164 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0662 | 0.0578 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0226 | 0.4526 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0662 | 0.0578 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.1256 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0226 | 0.4526 | 1 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0226 | 0.4526 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.007 | 0.1336 | 0.5 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0133 | 0.0044 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0226 | 0.4526 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0622 | 0.0608 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0226 | 0.4526 | 1 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0226 | 0.4526 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 1 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0226 | 0.4526 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.007 | 0.1336 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0226 | 0.4526 | 0.5 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0156 | 0.3105 | 0.5 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0226 | 0.4526 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0226 | 0.4526 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trypanosoma brucei | low molecular weight protein tyrosine phosphatase, putative | 0.007 | 0.1336 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0662 | 0.0648 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0622 | 0.1113 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0622 | 0.1119 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.007 | 0.1336 | 0.2951 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0226 | 0.4526 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.1416 | 0.1403 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.007 | 0.1336 | 0.2951 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0133 | 0.0044 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0226 | 0.4526 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.007 | 0.1336 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0074 | 0.0164 |
Onchocerca volvulus | 0.0226 | 0.4526 | 1 | |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0662 | 0.0648 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 16.2 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | = 22.671 uM | PubChem BioAssay. Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | > 59.64 uM | PubChem BioAssay. Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | > 59.64 uM | PubChem BioAssay. Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 80 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, in an orthogonal absorbance-based assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.0787 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (binding) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.